NextPlat (NXPL) investor relations material

Business overview

• Operates as a global consumer products and services company focused on healthcare and technology solutions via e-commerce and retail channels worldwide.

• Serves over 60,000 customers in 150+ countries, including businesses, governments, and healthcare organizations.

• Listed on Nasdaq under ticker NXPL, with 2.7 million shares outstanding and a $18.8 million market cap as of July 2026.

• Reported $54.3 million in consolidated revenues for 2025 and $11 million in cash as of March 2026.

Strategic focus and turnaround

• Refocused on high-growth sectors: healthcare, consumer wellness, and satellite connectivity.

• Implemented company-wide efficiency and process improvements, reducing annualized overhead by over $2 million and staff by 25%.

• Shifted from retail pharmacy to high-margin contracted offerings, expanding healthcare services nationwide.

• Expanded e-commerce operations domestically and internationally, including new product launches and partnerships.

Operational and financial performance

• Achieved record consolidated gross margin of 35% in Q1 2026, with new high-margin prescription volumes exceeding 7,500 per month.

• Healthcare revenue expanded from a single state to all 50 states, with new online prescription and fulfillment offerings.

• Q1 2026 revenue was $9.9 million, with a net loss of $1.1 million and continued improvements in operating expenses.

• Clean balance sheet with no long-term debt and high insider ownership (46%).